UNSPSC 51431903: Exaprolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, Q4XX54I93R chemically known as 2-propanol, 1-(2-cyclohexylphenoxy)-3-((1-methylethyl)amino)-,(+/-)- but generally known as exaprolol, which bears US NIH Compound Identifier 65485. European Medicines Agency schedules Exaprolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07491MIG. The term EXAPROLOL is an International Non-Proprietary Name or INN.

Most nations schedule exaprolol under HS 29221980 and SITC 51461. As of Q4 2014, EXAPROLOL remains the US FDA Preferred Term for this commodity. Exaprolol bears US NLM identifiers UMLS ID C0059928 and NCI Concept Code C65609. SMILES: CC(C)NCC(COC1=CC=CC=C1C2CCCCC2)O.

UNSPSC 51431903 Exaprolol, a Commodity code, encompasses emergency-response and hospital medications that state and local governments procure for fire rescue services, emergency medical systems, and pharmacy benefit programs. The code captures the actual procurement of branded or generic pharmaceutical products—in this case exaprolol and related advanced life support agents—supplied through competitive bidding to public health agencies. Issuing bodies include city purchasing departments (Tampa Fire Rescue), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving participating state and local government facilities). The mix reflects direct municipal procurement alongside statewide and interstate cooperative vehicles that aggregate demand across multiple jurisdictions.

Recent activity shows Tampa's City Purchasing Department issuing IFB 26P00188 for Advanced Life Support Medications (response due April 8, 2026, estimated contract value $40,000.00) requiring 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with nine-month minimum expiration dates and delivery within ten calendar days; the City applied a 5 percent SLBE bid discount. Minnesota's multistate cooperative purchasing alliance posted an RFP (response due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, requiring cGMP and DSCSA compliance, pricing flexibility across flat, net, and WAC-minus structures, and a two-year contract term with optional extensions. Texas HHS Commission issued an RFI (April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional PBM and wholesaler channels. Geographic activity spans Florida, Texas, and Minnesota; the MMCAP cooperative model pulls in Oregon and other participating jurisdictions. The code shows active demand from both individual municipalities and statewide cooperative purchasing vehicles, with contracts typically spanning one to two years and volumes tied to emergency response and institutional health-system supply chains.